This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Pharma Company. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Eddine Saiah: Innovator in Antithrombotic Agents
Introduction
Eddine Saiah is a notable inventor based in La Jolla, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antithrombotic agents. His work focuses on innovative compounds that can modulate the coagulation cascade, which is crucial for preventing blood clots.
Latest Patents
Eddine Saiah holds a patent for "Tetrahydroquinoline derivatives as antithrombotic agents." This invention relates to tetracyclic tetrahydroquinoline compounds and their analogues, which serve as selective inhibitors of serine protease enzymes, especially factor VIIa. The patent also covers pharmaceutical compositions containing these compounds and methods for their use as anticoagulant agents.
Career Highlights
Eddine Saiah is currently employed at Bristol-Myers Squibb Pharma Company, where he continues to advance his research in the pharmaceutical industry. His innovative work has the potential to impact the treatment of various coagulation disorders.
Collaborations
Throughout his career, Eddine has collaborated with esteemed colleagues, including Jinglan Zhou and Leslie Ann Robinson. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic agents.
Conclusion
Eddine Saiah's contributions to the field of antithrombotic agents exemplify the importance of innovation in pharmaceuticals. His work not only advances scientific knowledge but also holds promise for improving patient care in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile